ArticleClinical and translational medicine2024
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.
Xiaoqing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it